Listed

Adaptimmune Therapeutics PLC

ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31

Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adaptimmune Therapeutics PLC, Reports and events
FiledFormWhat it isAccession number
2016-03-1707:38 ET20-FAnnual report of a foreign private issuerPeriod 2015-12-310001104659-16-105686
2016-02-1614:01 ET8-K8.01 Other events0001104659-16-097213
2016-02-1215:04 ET8-K5.02 Departure or appointment of officers or directors0001104659-16-096544
2016-02-1010:32 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-095319
2016-02-0314:29 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-16-093515
2016-01-0814:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-16-088859
2015-12-1716:17 ET6-KReport of a foreign private issuerPeriod 2015-12-170001104659-15-085521
2015-12-1508:20 ET6-KReport of a foreign private issuerPeriod 2015-12-150001104659-15-084798
2015-12-0311:54 ET6-KReport of a foreign private issuerPeriod 2015-12-030001104659-15-082655
2015-11-2412:57 ET6-KReport of a foreign private issuerPeriod 2015-11-240001104659-15-081055
2015-11-1920:53 ETSC 13D/AOwnership report, active investor, amended0000947871-15-000841
2015-11-1807:00 ET6-KReport of a foreign private issuerPeriod 2015-11-180001104659-15-079788
2015-11-1307:34 ET6-KReport of a foreign private issuerPeriod 2015-11-130001104659-15-078491
2015-11-1214:32 ET6-KReport of a foreign private issuerPeriod 2015-11-120001104659-15-078238
2015-11-0510:50 ET6-KReport of a foreign private issuerPeriod 2015-11-050001104659-15-076100
2015-10-2213:30 ET6-KReport of a foreign private issuerPeriod 2015-10-220001104659-15-072120
2015-10-1916:40 ET6-KReport of a foreign private issuerPeriod 2015-10-190001104659-15-071383
2015-10-1316:40 ET20-FAnnual report of a foreign private issuerPeriod 2015-06-300001104659-15-070414
2015-10-1306:10 ET6-KReport of a foreign private issuerPeriod 2015-10-130001104659-15-070216
2015-10-0915:50 ET6-KReport of a foreign private issuerPeriod 2015-10-090001104659-15-070120
2015-09-1516:35 ET6-KReport of a foreign private issuerPeriod 2015-09-140001104659-15-065280
2015-09-1014:31 ET6-KReport of a foreign private issuerPeriod 2015-09-100001104659-15-064519
2015-09-0210:08 ET6-KReport of a foreign private issuerPeriod 2015-09-020001104659-15-063166
2015-07-2015:08 ET6-KReport of a foreign private issuerPeriod 2015-07-200001104659-15-051885
2015-07-0216:06 ET6-KReport of a foreign private issuerPeriod 2015-07-020001104659-15-049613
2015-06-0113:16 ET6-KReport of a foreign private issuerPeriod 2015-06-010001104659-15-042343
2015-05-2117:25 ET6-KReport of a foreign private issuerPeriod 2015-05-210001104659-15-040051
2015-05-1514:40 ETSC 13DOwnership report, active investor0000947871-15-000391
2015-05-1310:14 ET6-KReport of a foreign private issuerPeriod 2015-05-130001104659-15-037491

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.